search
ESGCT
Trends
- 1Editas Medicine to Present Gene-Editing Data at ESGCT Congress●Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference
Editas Medicine said it will present posters at the European Society of Gene and Cell Therapy's 33rd Annual Congress and take part in an upcoming investor conference. The gene-editing company did not disclose further details in the announcement, and no data summaries or pipeline updates were included with the initial notice.